Free Trial
NASDAQ:PMCB

Nuvilex (PMCB) Stock Price, News & Analysis

Nuvilex logo
$1.10 -0.04 (-3.42%)
As of 07/3/2025 01:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Nuvilex Stock (NASDAQ:PMCB)

Key Stats

Today's Range
$1.10
$1.13
50-Day Range
$1.00
$1.29
52-Week Range
$1.00
$2.42
Volume
4,487 shs
Average Volume
19,633 shs
Market Capitalization
$7.55 million
P/E Ratio
1.49
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nuvilex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

PMCB MarketRank™: 

Nuvilex scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Nuvilex.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nuvilex is 1.49, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.66.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nuvilex is 1.49, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.66.

  • Price to Book Value per Share Ratio

    Nuvilex has a P/B Ratio of 0.34. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Nuvilex's valuation and earnings.
  • Percentage of Shares Shorted

    0.35% of the float of Nuvilex has been sold short.
  • Short Interest Ratio / Days to Cover

    Nuvilex has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nuvilex has recently increased by 29.88%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nuvilex does not currently pay a dividend.

  • Dividend Growth

    Nuvilex does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.35% of the float of Nuvilex has been sold short.
  • Short Interest Ratio / Days to Cover

    Nuvilex has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nuvilex has recently increased by 29.88%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    1 people have searched for PMCB on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nuvilex insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.20% of the stock of Nuvilex is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 34.24% of the stock of Nuvilex is held by institutions.

  • Read more about Nuvilex's insider trading history.
Receive PMCB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuvilex and its competitors with MarketBeat's FREE daily newsletter.

PMCB Stock News Headlines

MyMD Pharmaceuticals Secures Strategic Investments
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
PharmaCyte Biotech Inc PMCB
PharmaCyte Biotech Invests In Femasys - Quick Facts
See More Headlines

PMCB Stock Analysis - Frequently Asked Questions

Nuvilex's stock was trading at $1.57 at the start of the year. Since then, PMCB stock has decreased by 29.9% and is now trading at $1.1010.

Nuvilex Inc. (NASDAQ:PMCB) released its earnings results on Monday, March, 17th. The company reported ($0.10) earnings per share (EPS) for the quarter.

Shares of PMCB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nuvilex investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), ASML (ASML), GE Aerospace (GE), Oracle (ORCL) and Nokia (NOK).

Company Calendar

Last Earnings
3/17/2025
Today
7/06/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
4/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PMCB
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
1.49
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$330 thousand
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$3.27 per share
Price / Book
0.34

Miscellaneous

Free Float
6,164,000
Market Cap
$7.55 million
Optionable
Optionable
Beta
-0.42
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:PMCB) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners